How we use Cookies

‘This drug ban beggars belief’

A SOLIHULL woman, battling multiple sclerosis, has slammed a local decision to ban a drug used to treat the condition.

A SOLIHULL woman, battling multiple sclerosis, has slammed a local decision to ban a drug used to treat the condition.

Heather Wilson, a retired HSBC worker, suffers from progressive MS and is furious that she’s unable to access Sativex simply because she lives in the Midlands.

The 68-year-old, spent three years on the ‘Cupid trial’ – giving her access to a cannabis-based drug that is similar to the Sativex.

“The other drug was so successful, I was out of pain and I was able to sleep. I could do away with the other three drugs I take,” she said.

Heather, who needs to have her drugs prescribed by a neurologist, says the new rule means she cannot access Sativex unless she buys it from a website in Scotland – at £500 a time.

“We are going back to the postcode lottery,” she said, “I would just like to try the Sativex.

“I go to bed at night and instead of being able to relax, I am very stiff in my body.

“With the ‘Cupid trial’ I was able to go to bed and sleep for eight hours straight.”

Jayne Spink, from the MS Society, said: “This decision beggars belief. Sativex has undergone extensive clinical testing over many years.

“It’s a national disgrace that people with MS in the UK are already amongst the least likely in Europe to have access to MS drugs.”

The Midland Therapeutics Review & Advisory Committee took the decision to ban the drug last month, becoming the first in the country to do so.

A report by the organisation argues that there’s “inadequate” evidence about the drug’s effectiveness and safety.

However the drug is available elsewhere in the UK.

 

Journalists

Cathrina Hulse
Multimedia Journalist
Annette Belcher
Multimedia Journalist
Full newsroom contact details
Tell us what's happening in your area.